Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acotec Scientific HoldingsHKSE:06669 -1.96%76 Pretax Margin % is 11.14% as of Dec. 2025, which is 13% above its 10-year median of 9.85. GuruFocus rates HKSE:06669 with a GF Score™ of 76/100 and a GF Value™ of HK$14.84 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Acotec Scientific Holdings ranks worse than 62.99% on this metric.
The historical rank and industry rank for Acotec Scientific Holdings's Pretax Margin % or its related term are showing as below:
HKSE:06669'
s Pretax Margin % Range Over the Past 10 Years
Min: -22.13 Med: 9.85 Max: 21.38
Current: -8.07
HKSE:06669's Pretax Margin % is ranked worse than 62.99% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.01
vs HKSE:06669: -8.07
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Acotec Scientific Holdings Pretax Margin % Related Terms
Acotec Scientific Holdings Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:06669 vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, Acotec Scientific Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acotec Scientific Holdings Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Acotec Scientific Holdings's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acotec Scientific Holdings (HKSE:06669) has a Pretax Margin % of 11.14% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Acotec Scientific Holdings and its competitors. This is 13% above median its historical median of 9.85. According to the industry distribution chart, Acotec Scientific Holdings ranks #514 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 63%.
Is Acotec Scientific Holdings' Pretax Margin % too high?
Acotec Scientific Holdings' current Pretax Margin % of 11.14% is 13% above median its 10-year median of 9.85. The Medical Devices & Instruments industry median Pretax Margin % is 3.01. Acotec Scientific Holdings' value of 11.14% is 270.1% above this industry median. Based on the distribution chart, Acotec Scientific Holdings ranks #514 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Acotec Scientific Holdings has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acotec Scientific Holdings' Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Acotec Scientific Holdings ranks #514 out of 816 companies for Pretax Margin %. This places Acotec Scientific Holdings in the lower half of its industry. The industry median Pretax Margin % is 3.01. Acotec Scientific Holdings' value of 11.14% is 270.1% above this benchmark. While the company's 10-year median is 9.85 vs. the industry median of 3.01, Acotec Scientific Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 3.01, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acotec Scientific Holdings's current Pretax Margin % of 11.14% is 270.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Acotec Scientific Holdings and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 3.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acotec Scientific Holdings's current Pretax Margin % is 11.14%, which is 13% above median its own 10-year median of 9.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acotec Scientific Holdings stock overvalued right now?
Based on GuruFocus' analysis, Acotec Scientific Holdings (HKSE:06669) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.84, compared to a current price of HK$6.24 — trading 58% below its estimated fair value. The current Pretax Margin % is 11.14%, which is 13% above median its 10-year median of 9.85 and 270.1% above the Medical Devices & Instruments industry median of 3.01. Acotec Scientific Holdings' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Acotec Scientific Holdings (HKSE:06669), the current Pretax Margin % is 11.14% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acotec Scientific Holdings (HKSE:06669) Overvalued in 2026?
Based on GuruFocus' analysis, Acotec Scientific Holdings stock appears to be undervalued.
The current stock price of HK$6.24 is trading 58% below its estimated GF Value™ of HK$14.84.
GuruFocus considers Acotec Scientific Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:06669:
Pretax Margin %: 11.14% (13% above median its 10-year median of 9.85)
GF Value™: HK$14.84 vs. price of HK$6.24 (58% below fair value)
Industry Position: 270.1% above the Medical Devices & Instruments median (#514 of 816)
No single metric tells the full story. See the HKSE:06669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions. The firm generates the majority of its revenue from sales to Domestic distributors.
76GF Score
Get the complete analysis for HKSE:06669
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06669 has been successfully added to your 
